コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nd that of its complex with a small-molecule cysteine protease inhibitor.
2 inhibited by the anti-prion compound E64, a cysteine protease inhibitor.
3 increasing concentrations of a vinyl sulfone cysteine protease inhibitor.
4 oxyoxirane-2-carbonyl)-L-leucyl]-agmatine, a cysteine protease inhibitor.
5 nhibition was abrogated by E-64, a selective cysteine protease inhibitor.
6 Excystation is blocked by specific cysteine protease inhibitors.
7 es and in infected erythrocytes treated with cysteine protease inhibitors.
8 ytes and belonging to the cystatin family of cysteine protease inhibitors.
9 en MARCH1-expressing cells were treated with cysteine protease inhibitors.
10 as metal ion-dependent, and not inhibited by cysteine protease inhibitors.
11 e degradation of TfR is partially blocked by cysteine protease inhibitors.
12 diminished specifically by lysosomal acidic cysteine protease inhibitors.
13 ut significant differences in sensitivity to cysteine protease inhibitors.
14 block in hemoglobin hydrolysis, as caused by cysteine protease inhibitors.
15 ly 2-fold) decreases in sensitivity to other cysteine protease inhibitors.
16 one-based triazoles as potential nonpeptidic cysteine protease inhibitors.
17 tivity was blocked by a subset of serine and cysteine protease inhibitors.
23 e critical interval: Ctla2b, which encodes a cysteine protease inhibitor, and mouse homologs of KIAA0
24 show that calpain inhibition through E64, a cysteine protease inhibitor, and the highly specific cal
26 ncoding human cystatin B, a widely expressed cysteine protease inhibitor, are responsible for a sever
27 1/2), members of the Serpin family of serine/cysteine protease inhibitors, are transcriptionally upre
29 d channels was also prevented by the caspase/cysteine protease inhibitor benzyloxycarbonyl-VAD-fluoro
30 induced apoptosis are blocked by the peptide cysteine protease inhibitor benzyloxycarbonyl-Val-Ala-As
31 nium (TEA), high extracellular potassium, or cysteine protease inhibitors block apoptosis induced by
37 gainst SARS-CoV, and that potent noncovalent cysteine protease inhibitors can be developed with speci
38 This study provides proof of concept that cysteine protease inhibitors can be given at therapeutic
39 esults in this report show that targeting of cysteine protease inhibitors can selectively control tum
40 eatment of mice with E-64, a highly specific cysteine protease inhibitor, completely inhibits sporozo
41 control tumor cell growth and that targeted cysteine protease inhibitors could prove valuable in the
42 procal decrease in the expression of several cysteine protease inhibitors (CPI), stefin A and cystati
46 er cell internalization of the extracellular cysteine protease inhibitor cystatin C, 12 variants of t
47 y-state mRNA and protein levels of two major cysteine protease inhibitors, cystatin B and C, were unc
48 SpeB- phase-shift forms in the presence of a cysteine protease inhibitor demonstrated differences in
49 nd mutant cDNAs into SCp2 cells and use of a cysteine protease inhibitor demonstrated that CDP is pro
50 whole cells, whereas in isolated nuclei, the cysteine protease inhibitors did not prevent the cleavag
51 Finally, we demonstrate that irreversible cysteine protease inhibitors do not abolish the Cif cyto
52 gan culture of transgenic lenses with E64, a cysteine protease inhibitor, dramatically delayed catara
53 s efficiently inhibited by both the covalent cysteine protease inhibitor E-64 and the reversible sele
54 DeltasigB mutant through the addition of the cysteine protease inhibitor E-64 or by using Staphostati
55 easome inhibitor, but not in response to the cysteine protease inhibitor E-64 or the calpain inhibito
56 proteases, since they were inhibited by the cysteine protease inhibitor E-64c but not by pepstatin A
57 tes were about 3 times more sensitive to the cysteine protease inhibitors E-64 and leupeptin, and ove
58 d) cathepsin B activity was inhibited by the cysteine protease inhibitors E-64, leupeptin, Mu-Np2-Hph
60 hibitor, dichloroisocoumarin, but not with a cysteine protease inhibitor, E-64, abrogated completely
62 ially blocked by treating the extract with a cysteine protease inhibitor, E-64, or by infecting BEAS-
68 d tolerance of antiherbivory defenses (i.e., cysteine protease inhibitors) expressed in soybean folia
69 ile and ubiquitously-expressed member of the cysteine protease inhibitor family that is present at no
70 ecific member of the cystatin superfamily of cysteine protease inhibitors, forms amyloid in vitro sug
71 Collectively, these results indicate that a cysteine protease inhibitor from bacterial origin could
72 ides evidence that cystatin B, a non-caspase cysteine protease inhibitor, has a role in preventing ce
73 rovides a general strategy for the design of cysteine protease inhibitors having high specificity to
74 out the efficacy, selectivity, and safety of cysteine protease inhibitors in cell culture or in vivo.
75 Bax protease activity is blocked in vitro by cysteine protease inhibitors including E-64 which distin
77 t the helminth immunomodulator AvCystatin, a cysteine protease inhibitor, induces a novel regulatory
78 vivo, and this cleavage was inhibited by the cysteine protease inhibitors iodoacetamide and N-ethylma
79 scular wall smooth muscle cells (SMCs), this cysteine protease inhibitor is severely reduced in both
81 c T-lymphocyte antigen-2beta (CTLA-2beta), a cysteine protease inhibitor, is expressed during PR-indu
82 ic), a member of the cystatin superfamily of cysteine protease inhibitors, is expressed in the epidid
84 hizonts were cultured in the presence of the cysteine protease inhibitor, l-transepoxy-succinyl-leucy
85 the cystatin B (CysB) gene, an intracellular cysteine protease inhibitor, lead to this human disease.
86 esis was tested directly by showing that the cysteine protease inhibitor leupeptin prevented Sp1 degr
88 he TAP-independent pathway is blocked by the cysteine protease inhibitor, leupeptin, but not by prote
90 2 x 10(-)(3) M [Ca(2+)](o) and 0.5 mM of the cysteine protease inhibitor, leupeptin, T:(g) increased
95 trin from the membrane and is blocked by the cysteine protease inhibitor N-acetyl-leucyl-leucyl-norle
96 ipain-active extracellular extracts with the cysteine protease inhibitor Nalpha-p-tosyl-l-lysine chlo
97 lasmepsin processing is not blocked by other cysteine protease inhibitors, nor by the proteasome inhi
98 h stage larvae (L4) by testing the effect of cysteine protease inhibitors on the survival of third st
100 se inhibitor 3,4-dichloroisocoumarin and the cysteine protease inhibitor p-(chloromercuri) benzenesul
104 ) ethyl chloromethyl ketone (TPCK), a serine-cysteine protease inhibitor, prevents the release of vir
110 structural analysis between the hCLD and the cysteine protease inhibitor stefin A showed why the hCLD
111 curs within lysosomes, as it is prevented by cysteine protease inhibitors such as E64, but not by the
112 JNK activation if apoptosis was blocked by a cysteine protease inhibitor, suggesting that under these
114 ter, is the prototype of this novel class of cysteine protease inhibitor that emerged from the search
115 drazides represent a new class of unreactive cysteine protease inhibitors that share a common mechani
118 lution as well as complexes with the general cysteine protease inhibitor trans-epoxysuccinyl-l-leucyl
119 virions was inhibited by the broad spectrum cysteine protease inhibitor trans-epoxysuccinyl-l-leucyl
121 Weak caseinolytic activity inhibitable by cysteine protease inhibitors was copurified with Cpl imm
122 l-characterized apoplastic effector EPIC1, a cysteine protease inhibitor, was also secreted from haus
123 shares homology with the cystatin family of cysteine protease inhibitors, we first analyzed the effe
126 nd post-ischemic cytoprotective effects of a cysteine protease inhibitor which does not block calpain
129 ystatins are a family of naturally occurring cysteine protease inhibitors, yet the target proteases a
130 up-regulation was completely blocked by the cysteine protease inhibitor Z-VAD-fmk (benzyloxycarbonyl
132 -induced cleavage of Mst1 was blocked by the cysteine protease inhibitor ZVAD-fmk, the more selective
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。